« Cormet Hip Resurfacing System The Cormet Hip Resurfacing System is | Main | FDA Approvals - Merck lays out expectations for 2008 (Philadelphia Business Journal) Merck »

Pharmaceutical, Healthcare & Life Sciences (Mondaq) Ted Acosta and Eileen


Pharmaceutical, Healthcare & Life Sciences (Mondaq)
Ted Acosta and Eileen Erdos of Ernst & Young discuss how companies facing ever-evolving regulatory requirements can address and assess compliance risk in their operating practices.
 

©2006 FDA-News.com. All rights reserved.